The firm acknowledges that Sunoco faces downside risks, which could stem from a negative shift in commodity market conditions or the economics of potential future projects and mergers and acquisitions.

Barclays analyst Balaji Prasad maintained a Hold rating on Pacira Pharmaceuticals (PCRX – Research Report) today and set a price target of

$180,000 of RBC CAPITAL MARKETS LLC (FORMERLY REGISTERED AS ROYAL BANK OF CANADA) lobbying was just disclosed, from Q4 of 2024, in a new Lobbying Disclosure Act filing. This included lobbying on ...

RBC Capital Markets has promoted Adam Ragol-Levy to head of European and Asian product, multi-asset agency solutions. The appointment follows three years serving as global multi-asset product manager at the firm, based in London. Prior to joining RBC ...

Victory Capital (NASDAQ:VCTR – Free Report) had its target price upped by Barclays from $69.00 to $70.00 in a report released on Friday morning,Benzinga reports. Barclays currently has an equal weight rating on the stock.

RBC Capital analyst Nelson Ng maintained a Hold rating on Methanex (MEOH – Research Report) on January 27 and set a price target of $55.00. The

RBC Capital analyst Jon Arfstrom maintained a Buy rating on American Express (AXP – Research Report) on January 24 and set a price target of

NextEra Energy (NYSE:NEE – Get Free Report) had its target price upped by research analysts at BMO Capital Markets from $82.00 to $84.00 in a research report issued to clients and investors on Monday.

On Friday, Exelixis Inc (EXEL) stock saw a decline, ending the day at $36.2 which represents a decrease of $-0.35 or -0.96% from the prior close of $36.55. The stock opened at $36.76 and touched a low of $35.99 during the day, reaching a high of $36.92. The volume of shares traded was 2.86 million exceeding the average volume of 2.27 million.

BMO Capital Markets has recently reduced Exelixis Inc (EXEL) stock to Market Perform rating, as announced on December 20, 2024, according to Finviz. Earlier, on December 17, 2024, BofA Securities had reduced the stock from a Buy to Neutral,

Wednesday saw a change in the outlook for Royal Bank of Canada (NYSE:RY) as Erste Group downgraded the bank's stock rating from Buy to Hold. The adjustment follows an analysis of the bank's financial performance and market position.

In a report released today, Douglas Miehm from RBC Capital assigned a Buy rating to Bausch + Lomb Corporation (BLCO – Research Report), with a